These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29976785)

  • 1. Adherence and long-term growth outcomes: results from the easypod
    Koledova E; Stoyanov G; Ovbude L; Davies PSW
    Endocr Connect; 2018 Aug; 7(8):914-923. PubMed ID: 29976785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to growth hormone (GH) therapy in naïve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS).
    Centonze C; Guzzetti C; Orlando G; Loche S;
    J Endocrinol Invest; 2019 Oct; 42(10):1241-1244. PubMed ID: 30968283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring Adherence Rate to Growth Hormone Therapy and Growth Outcomes in Taiwanese Children Using Easypod Connect: Observational Study.
    Su PH; Yang C; Chao MC; Chiang CL
    JMIR Pediatr Parent; 2021 Jan; 4(1):e14774. PubMed ID: 33448936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence and long-term outcomes of therapy in paediatric patients in Greece using the easypod™ electromechanical device for growth hormone treatment: The phase IV multicentre easypod™ connect observational study (ECOS).
    Charmandari E; Vlachopapadopoulou E; Kyritsi EM; Sakellariou D; Koledova E; Nespithal K; Michalacos S
    Growth Horm IGF Res; 2020; 53-54():101336. PubMed ID: 32739654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
    Blanco-López A; Antillón-Ferreira C; Saavedra-Castillo E; Barrientos-Pérez M; Rivero-Escalante H; Flores-Caloca O; Calzada-León R; Rosas-Guerra CC; Koledova E; Chiquete E; Ayala-Estrada A
    J Endocrinol Invest; 2020 Oct; 43(10):1447-1452. PubMed ID: 32239476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of adherence to growth hormone treatment on 0-2 year catch-up growth in children with growth hormone deficiency.
    van Dommelen P; Koledova E; Wit JM
    PLoS One; 2018; 13(10):e0206009. PubMed ID: 30356273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connected health for growth hormone treatment research and clinical practice: learnings from different sources of real-world evidence (RWE)-large electronically collected datasets, surveillance studies and individual patients' cases.
    Boman N; Fernandez-Luque L; Koledova E; Kause M; Lapatto R
    BMC Med Inform Decis Mak; 2021 Apr; 21(1):136. PubMed ID: 33902570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of Adherence Monitoring in Adult Patients With Growth Hormone Deficiency Under Replacement Therapy: Preliminary Monocentric Data With Easypod
    Mancini A; Vergani E; Bruno C; Palladino A; Brunetti A
    Front Endocrinol (Lausanne); 2019; 10():416. PubMed ID: 31316468
    [No Abstract]   [Full Text] [Related]  

  • 9. Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device.
    Loche S; Salerno M; Garofalo P; Cardinale GM; Licenziati MR; Citro G; Caruso Nicoletti M; Cappa M; Longobardi S; Maghnie M; Perrone R
    J Endocrinol Invest; 2016 Dec; 39(12):1419-1424. PubMed ID: 27406716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence and long-term outcomes of growth hormone therapy with easypod™ in pediatric subjects: Spanish ECOS study.
    Rodríguez Arnao MD; Rodríguez Sánchez A; Díez López I; Ramírez Fernández J; Bermúdez de la Vega JA; Yeste Fernández D; Chueca Guindulain M; Corripio Collado R; Pérez Sánchez J; Fernández González A
    Endocr Connect; 2019 Sep; 8(9):1240-1249. PubMed ID: 31484160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to r-hGH Therapy in Pediatric Growth Hormone Deficiency: Current Perspectives on How Patient-Generated Data Will Transform r-hGH Treatment Towards Integrated Care.
    Savage MO; Fernandez-Luque L; Graham S; van Dommelen P; Araujo M; de Arriba A; Koledova E
    Patient Prefer Adherence; 2022; 16():1663-1671. PubMed ID: 35846871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yearly Height Gain Is Dependent on the Truly Received Dose of Growth Hormone and the Duration of Periods of Poor Adherence: Practical Lessons From the French Easypod™ Connect Multicenter Observational Study.
    Coutant R; Nicolino M; Cammas B; de Buyst V; Tauber M; Hamel JF
    Front Endocrinol (Lausanne); 2021; 12():790169. PubMed ID: 35126310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of nurse-led virtual reviews with growth hormone device-linked patient adherence information: a mixed methods feasibility study.
    Stokes H; Jones J; Worth C; Nicholson J; Fullwood C; Banerjee I
    Front Endocrinol (Lausanne); 2023; 14():1167854. PubMed ID: 37324260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to Growth Hormone Treatment Using a Connected Device in Latin America: Real-World Exploratory Descriptive Analysis Study.
    Assefi A; van Dommelen P; Arnaud L; Otero C; Fernandez-Luque L; Koledova E; Calliari LE
    JMIR Mhealth Uhealth; 2022 Jan; 10(1):e32626. PubMed ID: 35049518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. User trial of Easypod, an electronic autoinjector for growth hormone.
    Tauber M; Payen C; Cartault A; Jouret B; Edouard T; Roger D
    Ann Endocrinol (Paris); 2008 Dec; 69(6):511-6. PubMed ID: 18589398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of adherence on growth response during the first 2 years of growth hormone treatment.
    de Arriba Muñoz A; Muñiz VC; Saez JJA; Beisti A; Llovet E; Aizpún JIL
    Endocrine; 2021 May; 72(2):513-523. PubMed ID: 33284395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Augmented Reality Mobile App (Easypod AR) as a Complementary Tool in the Nurse-Led Integrated Support of Patients Receiving Recombinant Human Growth Hormone: Usability and Validation Study.
    Baños RM; Peltonen LM; Martin B; Koledova E
    JMIR Nurs; 2023 Apr; 6():e44355. PubMed ID: 37083627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy.
    Foo J; Maghnie M; Colao A; Vlachaki I; Colombo G
    Clinicoecon Outcomes Res; 2019; 11():525-537. PubMed ID: 31692496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.